Richard Fatica is a Nephrology physician affiliated with Cleveland Clinic. OpenAlex indexes 80 publications with 2,391 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 17 Jan 2014.
Clinical trials
- Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
Sponsor: Richard Fatica
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Otsuka America Pharmaceutical, Inc.Program year20252 payments
- Recor Medical IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
36.9%Beta blocker10.5%Carvedilol50%Metoprolol Tartrate24%Metoprolol Succinate20%Labetalol Hcl7%Part D<11 patientsCalcium channel blocker7.7%Amlodipine Besylate75%Nifedipine Er14%Diltiazem 24hr Er (Cd)10%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
25.2%Corticosteroid17.7%Prednisone100%Part D≥75 patientsProton pump inhibitor4.9%Pantoprazole Sodium56%Omeprazole44%Part D<11 patients+ 3 more classes in this area
Anti-infectives
20.1%Short-acting sulfonamides16.5%Sulfamethoxazole-Trimethoprim100%Part D≥72 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3%Valganciclovir Hcl100%Part D≥17 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection
Kidney International Reports
2025 - Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants
American Journal of Transplantation
2025 - Early Onset Bacteremia in Deceased Donor Kidney Transplant Recipients at a Large Volume Transplant Center: Characteristics and Risk Factors
American Journal of Transplantation
2025 - Subthreshold rejection activity in many kidney transplants currently classified as having no rejection
American Journal of Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”